Javier Leon

Santander, CB 39011, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

CTCF Regulates Erythroid Differentiation Through Control of Core Erythroid Transcription Factors.

CTCF Regulates Erythroid Differentiation Through Control of Core Erythroid Transcription Factors.

Journal: Biomolecules

Published: February 23, 2026

The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.

The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.

Journal: Cancers

Published: September 26, 2024

ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity-independent manner.

ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity-independent manner.

Journal: Science signaling

Published: July 18, 2023

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.

Journal: Oncogene

Published: February 01, 2023

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia.

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 03, 2021

Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathway.

Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathway.

Journal: Oncogenesis

Published: August 03, 2021

The Multiple Faces of MNT and Its Role as a MYC Modulator.

The Multiple Faces of MNT and Its Role as a MYC Modulator.

Journal: Cancers

Published: July 19, 2021

A novel role of MNT as a negative regulator of REL and the NF-κB pathway.

A novel role of MNT as a negative regulator of REL and the NF-κB pathway.

Journal: Oncogenesis

Published: April 10, 2020

Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.

Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.

Journal: Scientific reports

Published: August 20, 2019

The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

Journal: The Journal of biological chemistry

Published: July 28, 2019

MYC Oncogene Contributions to Release of Cell Cycle Brakes.

MYC Oncogene Contributions to Release of Cell Cycle Brakes.

Journal: Genes

Published: February 24, 2019

Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells.

Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells.

Journal: Scientific reports

Published: January 10, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026